TITAN PHARMACEUTICALS INC — Director's Dealing 2005

Aug 11, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTP)
CIK: 0000910267
Period of Report: 2005-08-09

Reporting Person: MACFARLANE M DAVID (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-08-09	Stock Option (Right to Buy)	$2.05	A	10000	Acquired	2015-08-09	Common Stock (10000)	Direct

Footnotes

F1: These options vest in equal installments over a 12-month period commencing on the date of grant.